10 principais regenxbio.com concorrentes

askbio.com

Leading gene therapy company announces $235 million investment to accelerate growth

outlooktherapeutics.com

Faisal G. Sukhtian Mr. Sukhtian has served as Chairman since 2025 and has served as a member of Outlook Therapeutics’ Board of Directors since 2017. Mr. Sukhtian is the Executive Director at GMS Holdings. Faisal oversees a number of investments within the GMS Holdings portfolio and serves as a director on the company's

genentech-clinicaltrials.com

Genentech Clinical Trials is an informational resource for patients, caregivers, and doctors to find clear and simple language about clinical trials and inclus...

fightingblindness.org

Welcome to our livestream series, Music to Our Eyes. In each episode, we sit down with various artists to discuss their experiences with vision loss and discuss their commitment to creating music that celebrates diversity and belonging.

macular.org

Award winning documentary about living with vision loss from macular degeneration from The American Macular Degeneration Foundation

bluerocktx.com

BlueRock Therapeutics wants you to understand how information is collected, used and disclosed.

kitepharma.com

Learn about Kite’s mission to change the way cancer is treated with cell therapy – the use of genetically modified immune cells programmed to target tumors.

stemcell.ucla.edu

Take the elevator up to the 14th floor of the Factor Building at UCLA and you’ll find two things: striking views of the greater San Fernando Valley — marine layer permitting — and scientists covered head-to-toe in protective gear transforming scientific discoveries into new, innovative cell therapies.

curevac.com

The extraordinary general meeting (“EGM”) of the shareholders of CureVac N.V. will take place on Tuesday, March 28, 2023, starting from 2 p.m. Central European Summer Time.

biomarin.com

Healthcare professionals and patients may report information on adverse events by submitting a form or contacting us by email or fax.